Please make a selection from the following news articles in Drug Trials.
STATEMENT ON THREE DRUG THERAPY IN THE TREATMENT OF ALS |
Date Posted: Wednesday, September 10, 2003 |
A meeting of the Canadian Phase IV Riluzole Study (ALS-601) Steering Committee was recently convened to discuss the use of Riluzole-Nimodipine-Minocycline combination therapy in the treatment of ALS and its implication with respect to the conduct of... |
|
|
Novartis ALS Trial - Closes July 15th |
Date Posted: Friday, July 12, 2002 |
Recruitment for the Novartis ALS trial (TCH102) will close on July 15th. There are plans for more trials with the compound TCH346, although the results from the 102 trial will be required before going ahead. We will keep you informed of future... |
|
|
ALS drug trial announced |
Date Posted: Friday, February 08, 2002 |
Novartis Pharmaceuticals Canada Inc. is currently sponsoring a phase II clinical trial in Amyotrophic Lateral Sclerosis (ALS) with their compound TCH346. The objectives of the study are to establish the safety of TCH346, and to look for evide... |
|
|
Canadian sites for Myotrophin clincal trial |
Date Posted: Friday, January 25, 2002 |
The clinical trial of insulin-like growth factor-1 (IGF-1) or Myotrophin will be carried out at two Canadian sites. The study is being led by the Mayo Medical Center in Rochester, Minnesota and the Great Lakes ALS and is co-funded by the Ameri... |
|
|
Drug Trial Information - An Article |
Date Posted: Thursday, September 27, 2001 |
Seminars in Neurology [Sem Neurology 21(2):167-175, 2000. © 2000 Thieme Medical Publishers, Inc.] Thieme Medical Publishers, Inc.is the exclusive copyright holder of this work and therefore direct copyright infringement is in violation of U... |
|
|
Drug Trial Information |
Date Posted: Thursday, September 27, 2001 |
Thieme Medical Publishers has given the ALS Society of Canada permission to post this article on clinical drug trials. Please adhere to the copyright agreement below. The article offers up-to-date information about ALS drug trials and is inte... |
|
|
